We believe in
overcoming problems
by going into the
first principles
of science.
We believe in overcoming problems by going into the first principles of science.
Rubicon Research has 2 state-of-the-art R&D centers in India and Canada.
Our R&D Centers
1. Rubicon Research Corporate HQ and R&D Center in Thane, India
Commissioned in 2018, the 38,000 square feet modern facility focuses on formulation development and drug product analytical development. There are three formulation facilities.
2. Rubicon Research Canada HQ and R&D Center, Concord, Canada
Our R&D center in Ontario, Canada is housed in a 13,609.69 square feet facility with laboratories built to cGMP standards and analytical and characterization capabilities for nasal and inhalation products. This R&D Centre is for formulation of nasal and inhalation products such as nasal sprays, dry powder inhalers, metered dose inhalers, etc.
The table below provides details of our R&D centers, as of March 31, 2024:
| Location | Segment | Description |
|---|---|---|
| Thane, Maharashtra, India |
Multi-segment | R&D centers for formulations across various dosage forms, including oral solids, oral liquids, injectables, ophthalmic, and topicals. |
| Ontario, Canada | Nasal & inhalation | R&D centers for formulation of nasal and inhalation products such as nasal sprays, dry powder inhalers, metered dose inhalers, etc. |